Moreover, some related studies have identified impaired expression of the GPX4 gene in PBMCs from breast cancer patients which could serve as a biomarker indicating an increased risk for breast cancer [52], indicating that the expression of GPX4 in PBMCs is indeed related to some particular disease. The gene discussed is GPX4; the disease is breast carcinoma.